Survival analysis of a 16-year cohort of follicular lymphoma patients receiving systemic treatment in Brazil
IntroductionFollicular lymphoma (FL) is a common type of non-Hodgkin lymphoma that is incurable but often follows an indolent course. While survival is improving thanks to advances in diagnosis, supportive care, and new therapies, understanding outcomes and their impact on overall survival is still...
Saved in:
Main Authors: | Pamela Santos Azevedo, Isabella Zuppo Laper, Deborah Marta do Santos Oliveira, Adriano de Paula Sabino, Marina Morgado Garcia, Isabela Cristina Menezes de Freitas, Wallace Mateus Prata, Mariângela Leal Cherchiglia, Juliana Álvares-Teodoro, Francisco de Assis Acurcio, Augusto Afonso Guerra Júnior |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1414244/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality
by: Alejandra Adriana Cardoso de Castro, et al.
Published: (2025-01-01) -
Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis
by: Ze‐Long Liu, et al.
Published: (2019-03-01) -
Rituximab-induced serum sickness: Not so uncommon
by: Vikramraj K Jain
Published: (2018-01-01) -
Exploration of rituximab treatment strategies for membranous nephropathy adapted to the Chinese healthcare environment
by: Xiaolong Wang, et al.
Published: (2025-01-01) -
Transition of Thyroid Autoantibodies by Rituximab Treatment in Women with Rheumatoid Arthritis
by: Hüseyin Demirci, et al.
Published: (2024-10-01)